Literature DB >> 10981208

Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: an application of multilevel models.

J E Brown1, M T King, P N Butow, S M Dunn, A S Coates.   

Abstract

BACKGROUND: Quality of life (QOL) assessment is an important component within cancer research. There is often variability in QOL scores both between patients and across time. Understanding this variability in terms of personal characteristics and psychosocial factors would be useful but is often obstructed by the types of analyses that are applied to longitudinal data sets. Improved understanding can be gained with the application of multi-level or hierarchical models that allow for greater flexibility for modelling individual patterns of change over time. METHODS AND PATIENTS: Questionnaires were sent to a cohort of stage IV melanoma patients seen at the Sydney Melanoma Unit between 1991 and 1996, approximately every 3 months for up to 2 years. The data reported here are from a sub-sample of 44 patients who each completed between 3 and 8 questionnaires. Three aspects of QOL were measured (effort to cope, mood and physical well-being), each with a single LASA line. Multilevel techniques were used to model the patterns of QOL over time. Covariates were added to explain variation between patients in their average QOL and change in QOL over time.
RESULTS: The scores of each of the three QOL measures showed marked fluctuations over time. However, there was little systematic change during the study in either effort to cope (p = 0.32) or mood (p = 0.06). In contrast, the physical well-being scores of some patients improved while others deteriorated (p < 0.001). On average, physical well-being deteriorated (p < 0.001). Variability between patients accounted for 60% (effort to cope), 45% (mood) and 44% (physical well-being) of the total variance of each scale. A range of psycho-social factors including active and avoidant coping styles and psychological adjustment accounted for significant amounts of the variability between patients in each QOL measure.
CONCLUSION: Individual coping and psychological adjustment are related to individual changes in QOL and to differences among patients' QOL. The study illustrates the use of multi-level techniques to further our understanding of differences between patients in their QOL and how it changes over time.

Entities:  

Mesh:

Year:  2000        PMID: 10981208     DOI: 10.1023/a:1008995814965

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  18 in total

1.  Do quality of life assessments make a difference in the evaluation of cancer treatments?

Authors:  C M Moinpour
Journal:  Control Clin Trials       Date:  1997-08

2.  A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931.

Authors:  J E Herndon; S Fleishman; M P Kosty; M R Green
Journal:  Control Clin Trials       Date:  1997-08

3.  On the receiving end. VI. Which dimensions of quality-of-life scores carry prognostic information?

Authors:  A Coates; V Gebski
Journal:  Cancer Treat Rev       Date:  1996-01       Impact factor: 12.111

4.  Multi-level models for repeated measurement data: application to quality of life data in clinical trials.

Authors:  H J Beacon; S G Thompson
Journal:  Stat Med       Date:  1996-12-30       Impact factor: 2.373

5.  Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes.

Authors:  S Folkman; R S Lazarus; C Dunkel-Schetter; A DeLongis; R J Gruen
Journal:  J Pers Soc Psychol       Date:  1986-05

6.  Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy.

Authors:  A Coates; F Porzsolt; D Osoba
Journal:  Eur J Cancer       Date:  1997-06       Impact factor: 9.162

Review 7.  Coping theory and research: past, present, and future.

Authors:  R S Lazarus
Journal:  Psychosom Med       Date:  1993 May-Jun       Impact factor: 4.312

8.  Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.

Authors:  J Bernhard; C Hürny; A S Coates; H F Peterson; M Castiglione-Gertsch; R D Gelber; A Goldhirsch; H J Senn; C M Rudenstam
Journal:  Ann Oncol       Date:  1997-09       Impact factor: 32.976

9.  Cancer by another name: a randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients.

Authors:  S M Dunn; P U Patterson; P N Butow; H H Smartt; W H McCarthy; M H Tattersall
Journal:  J Clin Oncol       Date:  1993-05       Impact factor: 44.544

10.  The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

Authors:  C Hürny; J Bernhard; M Bacchi; B van Wegberg; M Tomamichel; U Spek; A Coates; M Castiglione; A Goldhirsch; H J Senn
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

View more
  8 in total

Review 1.  Cost effectiveness and cost utility of adjuvant interferon alpha in cutaneous melanoma: a review.

Authors:  Ralph Crott
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Measures of asthma control and quality of life: longitudinal data provide practical insights into their relative usefulness in different research contexts.

Authors:  Madeleine T King; Patricia M Kenny; Guy B Marks
Journal:  Qual Life Res       Date:  2009-02-19       Impact factor: 4.147

3.  Melanoma survivorship: research opportunities.

Authors:  Susan A Oliveria; Jennifer L Hay; Alan C Geller; Maureen K Heneghan; Mary S McCabe; Allan C Halpern
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

4.  Using individual growth model to analyze the change in quality of life from adolescence to adulthood.

Authors:  Henian Chen; Patricia Cohen
Journal:  Health Qual Life Outcomes       Date:  2006-02-21       Impact factor: 3.186

5.  Health profiles of 996 melanoma survivors: the M. D. Anderson experience.

Authors:  Charles Stava; Martha Beck; L Todd Weiss; Adriana Lopez; Rena Vassilopoulou-Sellin
Journal:  BMC Cancer       Date:  2006-04-18       Impact factor: 4.430

6.  The use of denial in an ethnically diverse British cancer population: a cross-sectional study.

Authors:  R Roy; R P Symonds; D M Kumar; K Ibrahim; A Mitchell; L Fallowfield
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

7.  Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma.

Authors:  J E Brown; P N Butow; G Culjak; A S Coates; S M Dunn
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

8.  Assess quality of life among Iranian married women residing in rural places.

Authors:  Seddigheh Esmaeilzadeh; Mouloud Agajani Delavar; Mohammad Hadi Aghajani Delavar
Journal:  Glob J Health Sci       Date:  2013-05-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.